Bi-Specific MAbS Global Market Size, Share, Trends Analysis, By Source Type, By Production Type, By Application, By End-use, By Region And Segment Forecasts, 2022-2031

The global bi-specific MAbs market report by the business research company identifies the increasing prevalence of cancer and other chronic diseases is projected to contribute to the growth of the bispecific monoclonal antibodies market over the forecast period. Bispecific monoclonal antibodies are developed for the treatment of various cancers, infectious diseases, central nervous system disorders, and autoimmune disorders. Bispecific monoclonal antibodies are considered to be more effective than monoclonal antibodies (moAbs) as these targets two or more tumor antigens on cells to disrupt cancer progression. According to the World Health Organization, cancer is the leading cause of death worldwide and is responsible for around 10 million deaths in 2020. Additionally, according to the Centers for Disease Control and Prevention, chronic diseases are among the most prevalent diseases with 6 out of 10 adults suffering from at least one chronic disease in the USA. Therefore, a rising number of chronic diseases including cancer is anticipated to propel the demand for bi-specific MAbs market to treat these diseases effectively.

The global bi-specific mabs market is expected to grow from $3.80 billion in 2021 to $5.13 billion in 2022 at a compound annual growth rate (CAGR) of 34.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The bi-specific MAbs or bispecific monoclonal antibodies market is expected to reach $11.64 billion in 2026 at a CAGR of 22.7%.

Purchase The Bi-Specific MAbs Market Report Here:
https://www.thebusinessresearchcompany.com/report/bi-specific-mab-global-market-report

The regions covered in the bi-specific MAbs or bispecific monoclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the bi-specific MAbs market are Johnson & Johnson, Novartis AG, Hoffmann-La Roche Ltd., Novo Nordisk A/S, Bayer AG, Thermo Fisher Scientific, Inc., Bistro-Myers Squibb. Mylan N.V., Daiichi Sankyo Company Ltd. and Abbott.

The global bi-specific MAbs market is segmented -
1)By Type: Catumaxomab (Removab), Blinatumomab, Duligotumab, SAR 156597
2)By Product Type: In Vivo, In Vitro
3)By Indication: Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others
4)By End Use: Hospitals, Research Institutes, Others.

Request A Sample Of The Bi-Specific MAbs Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3390&type=smp

The Bi-Specific MAbs Market Report Contents Include
1. Executive Summary
2. Bi-Specific MAbS Market Characteristics
3. Bi-Specific MAbS Market Trends And Strategies
4. Bi-Specific MAbS Market - Macro Economic Scenario
5. Bi-Specific MAbS Market Size And Growth
.....
27. Bi-Specific MAbS Market Competitive Landscape And Company Profiles
28. Bi-Specific MAbS Pipeline Analysis
29. Key Mergers And Acquisitions In The Bi-Specific MAbS Market
30. Bi-Specific MAbS Market Future Outlook and Potential Analysis
31. Appendix

This report covers the trends and market dynamics of the bi-specific MAbs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.